- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6876 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Patent holdings for IPC class C12Q 1/6876
Total number of patents in this class: 3153
10-year publication summary
117
|
130
|
129
|
279
|
439
|
402
|
466
|
476
|
389
|
130
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
10X Genomics, Inc. | 921 |
61 |
The Regents of the University of California | 18943 |
60 |
Illumina, Inc. | 2771 |
53 |
President and Fellows of Harvard College | 5792 |
47 |
Natera, Inc. | 265 |
35 |
Becton, Dickinson and Company | 6712 |
33 |
Illumina Cambridge Limited | 678 |
31 |
University of Washington through its Center for Commercialization | 498 |
31 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
29 |
Prognosys Biosciences, Inc. | 95 |
29 |
Massachusetts Institute of Technology | 9795 |
26 |
The Johns Hopkins University | 5377 |
26 |
Life Technologies Corporation | 3068 |
25 |
Bio-Rad Laboratories, Inc. | 1592 |
24 |
The Broad Institute, Inc. | 1584 |
23 |
Gen-Probe Incorporated | 954 |
22 |
F. Hoffmann-La Roche AG | 7958 |
21 |
Cepheid | 318 |
19 |
Regeneron Pharmaceuticals, Inc. | 3650 |
19 |
Singular Genomics Systems, Inc. | 210 |
17 |
Other owners | 2522 |